BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 16145534)

  • 1. Diagnosis and treatment of atypical and anaplastic meningiomas: a review.
    Modha A; Gutin PH
    Neurosurgery; 2005 Sep; 57(3):538-50; discussion 538-50. PubMed ID: 16145534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atypical meningiomas.
    Chen R; Aghi MK
    Handb Clin Neurol; 2020; 170():233-244. PubMed ID: 32586495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of Atypical and Anaplastic Meningiomas.
    Buttrick S; Shah AH; Komotar RJ; Ivan ME
    Neurosurg Clin N Am; 2016 Apr; 27(2):239-47. PubMed ID: 27012388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An evidence-based treatment algorithm for the management of WHO Grade II and III meningiomas.
    Sun SQ; Hawasli AH; Huang J; Chicoine MR; Kim AH
    Neurosurg Focus; 2015 Mar; 38(3):E3. PubMed ID: 25727225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracranial meningiomas: diagnosis and treatment.
    Chamberlain MC; Blumenthal DT
    Expert Rev Neurother; 2004 Jul; 4(4):641-8. PubMed ID: 15853583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereotactic radiation treatment for recurrent nonbenign meningiomas.
    Mattozo CA; De Salles AA; Klement IA; Gorgulho A; McArthur D; Ford JM; Agazaryan N; Kelly DF; Selch MT
    J Neurosurg; 2007 May; 106(5):846-54. PubMed ID: 17542529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Meningiomas: new prognostic factors].
    Sanz Esponera J
    An R Acad Nac Med (Madr); 2007; 124(2):319-32; discussion 330-2. PubMed ID: 18069599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atypical and anaplastic meningiomas: prognostic implications of clinicopathological features.
    Yang SY; Park CK; Park SH; Kim DG; Chung YS; Jung HW
    J Neurol Neurosurg Psychiatry; 2008 May; 79(5):574-80. PubMed ID: 17766430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathodiagnostic parameters for meningioma grading.
    Moradi A; Semnani V; Djam H; Tajodini A; Zali AR; Ghaemi K; Nikzad N; Madani-Civi M
    J Clin Neurosci; 2008 Dec; 15(12):1370-5. PubMed ID: 18819804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the results of recurrent intracranial meningiomas treated with re-radiosurgery.
    Kim M; Lee DH; Kim Rn HJ; Cho YH; Kim JH; Kwon DH
    Clin Neurol Neurosurg; 2017 Feb; 153():93-101. PubMed ID: 28081463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Necrosis is a consistent factor to recurrence of meningiomas: should it be a stand-alone grading criterion for grade II meningioma?
    Góes P; Santos BFO; Suzuki FS; Salles D; Stávale JN; Cavalheiro S; de Paiva Neto MA
    J Neurooncol; 2018 Apr; 137(2):331-336. PubMed ID: 29270884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hitting a moving target: evolution of a treatment paradigm for atypical meningiomas amid changing diagnostic criteria.
    Pearson BE; Markert JM; Fisher WS; Guthrie BL; Fiveash JB; Palmer CA; Riley K
    Neurosurg Focus; 2008; 24(5):E3. PubMed ID: 18447742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current management of meningiomas.
    De Monte F
    Oncology (Williston Park); 1995 Jan; 9(1):83-91, 96; discussion 96, 99-101. PubMed ID: 7718443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of Treatment Response and Survival Outcomes in Meningioma Recurrence with Atypical or Anaplastic Histology.
    Chohan MO; Ryan CT; Singh R; Lanning RM; Reiner AS; Rosenblum MK; Tabar V; Gutin PH
    Neurosurgery; 2018 Jun; 82(6):824-832. PubMed ID: 28645194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromosomal alterations, prognostic factors, and targeted molecular therapies for malignant meningiomas.
    Yew A; Trang A; Nagasawa DT; Spasic M; Choy W; Garcia HM; Yang I
    J Clin Neurosci; 2013 Jan; 20(1):17-22. PubMed ID: 22743042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignant meningiomas.
    Fountain DM; Young AMH; Santarius T
    Handb Clin Neurol; 2020; 170():245-250. PubMed ID: 32586496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multimodal Management of Metastatic Malignant Meningiomas: The Role of Radiosurgery in Long-Term Local Control.
    Attuati L; Zaed I; Morselli C; Pecchioli G; Fornari M; Picozzi P
    World Neurosurg; 2019 Aug; 128():562-572. PubMed ID: 31102770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of 111In-pentetreotide scan in a subject with treatment refractory atypical meningioma.
    Bural GG; Lieberman F; Mountz JM
    Clin Nucl Med; 2014 Apr; 39(4):342-5. PubMed ID: 24445268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meningioma: not always a benign tumor. A review of advances in the treatment of meningiomas.
    Maggio I; Franceschi E; Tosoni A; Nunno VD; Gatto L; Lodi R; Brandes AA
    CNS Oncol; 2021 Jun; 10(2):CNS72. PubMed ID: 34015955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrence of intracranial meningiomas: did better methods of diagnosis and surgical treatment change the outcome in the last 30 years?
    Strassner C; Buhl R; Mehdorn HM
    Neurol Res; 2009 Jun; 31(5):478-82. PubMed ID: 19500450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.